Anna Eramo, M.D.

Equibles does not estimate personal net worth.

Get an email with a short summary when Lb Pharmaceuticals Inc publishes a filing, an earnings call transcript or a press release.

Get LBRX alerts

About Anna Eramo, M.D.

Lb Pharmaceuticals Inc reported in an 8-K filed June 10, 2026 that Anna Eramo, M.D. was appointed advisor, effective June 16, 2026. Lb Pharmaceuticals Inc is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Lb Pharmaceuticals Inc includes Heather Turner (CEO and Board Member), Joseph M. Miller (CFO), Gad Soffer (COO) and 1 other.

“On June 16, 2026, Anna Eramo, M.D., for personal reasons will transition to a role of advisor to LB Pharmaceuticals Inc (the "Company").”

Lb Pharmaceuticals Inc Form 8-K, filed June 10, 2026 · Read the filing

Affiliation history

Lb Pharmaceuticals Inc (LBRX)
SEC 8-K

Current
2026-06-16–present

Company network

Lb Pharmaceuticals Inc

LBRX

Current role

Biotechnology · Healthcare

Leadership on record at Lb Pharmaceuticals Inc

Heather Turner CEO, Board Member
Joseph M. Miller CFO
Gad Soffer COO
Robert A. Lenz Board Member

Recent activity

Executive change Appointed: advisor Lb Pharmaceuticals Inc (LBRX)
2026-06-16